Literature DB >> 12509764

The Fanconi anaemia/BRCA pathway.

Alan D D'Andrea1, Markus Grompe.   

Abstract

Fanconi anaemia (FA) is a rare genetic cancer-susceptibility syndrome that is characterized by congenital abnormalities, bone-marrow failure and cellular sensitivity to DNA crosslinking agents. Seven FA-associated genes have recently been cloned, and their products were found to interact with well-known DNA-damage-response proteins, including BRCA1, ATM and NBS1. The FA proteins could therefore be involved in the cell-cycle checkpoint and DNA-repair pathways. Recent studies implicate the FA proteins in the process of repairing chromosome defects that occur during homologous recombination, and disruption of the FA genes results in chromosome instability--a common feature of many human cancers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12509764     DOI: 10.1038/nrc970

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  277 in total

1.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Authors:  Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes.

Authors:  In Sil Choi; Hye Seung Lee; Keun-Wook Lee; Haeryoung Kim; Ki Hwan Kim; Yu Jung Kim; Jee Hyun Kim; Woo Ho Kim; Jong Seok Lee
Journal:  Med Oncol       Date:  2010-06-09       Impact factor: 3.064

3.  Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex.

Authors:  Peter S Brzovic; Jennifer R Keeffe; Hiroyuki Nishikawa; Keiko Miyamoto; David Fox; Mamoru Fukuda; Tomohiko Ohta; Rachel Klevit
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

4.  Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway.

Authors:  Andreas Rothfuss; Markus Grompe
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

Review 5.  Emerging roles of BRCA1 alternative splicing.

Authors:  T I Orban; E Olah
Journal:  Mol Pathol       Date:  2003-08

6.  Mutator genes for suppression of gross chromosomal rearrangements identified by a genome-wide screening in Saccharomyces cerevisiae.

Authors:  Stephanie Smith; Ji-Young Hwang; Soma Banerjee; Anju Majeed; Amitabha Gupta; Kyungjaem Myung
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

7.  Genomic instability in chronic myeloid leukemia: targets for therapy?

Authors:  N Muvarak; P Nagaria; F V Rassool
Journal:  Curr Hematol Malig Rep       Date:  2012-06       Impact factor: 3.952

Review 8.  The Fanconi anemia pathway and DNA interstrand cross-link repair.

Authors:  Xiaoyu Su; Jun Huang
Journal:  Protein Cell       Date:  2011-09-23       Impact factor: 14.870

9.  CCAAT/enhancer binding protein delta (C/EBPdelta, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage.

Authors:  Jun Wang; Tapasree Roy Sarkar; Ming Zhou; Shikha Sharan; Daniel A Ritt; Timothy D Veenstra; Deborah K Morrison; A-Mei Huang; Esta Sterneck
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

10.  DNA cross-link repair protein SNM1A interacts with PIAS1 in nuclear focus formation.

Authors:  Masamichi Ishiai; Masayo Kimura; Keiko Namikoshi; Mitsuyoshi Yamazoe; Kazuhiko Yamamoto; Hiroshi Arakawa; Kazunaga Agematsu; Nobuko Matsushita; Shunichi Takeda; Jean-Marie Buerstedde; Minoru Takata
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.